Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Marks Electrical Group (MRK) by Steve Moore in ShareProphets
- Avoid THG (THG) by Steve Moore in ShareProphets
- Buy Water Intelligence (WATR) by Hot Stock Rockets in ShareProphets
- Avoid Headlam Group (HEAD) by Steve Moore in ShareProphets
- Avoid Pinewood Technologies Group (PINE) by Steve Moore in ShareProphets
- Buy Abrdn (ABDN) by Tom Winnifrith in ShareProphets
- Buy Abrdn (ABDN) by Steve Moore in ShareProphets
- Buy Capital Limited (DI) (CAPD) by Hot Stock Rockets in ShareProphets
- Avoid Aptamer Group (APTA) by Steve Moore in ShareProphets
- Hold S4 Capital (SFOR) by Deutsche Bank
- Buy Ecora Resources (ECOR) by Berenberg
- Hold Kenmare Resources (CDI) (KMR) by Berenberg
- Buy Luceco (LUCE) by Deutsche Bank
- Outperform Ecora Resources (ECOR) by RBC Capital
- Buy BAE Systems (BA.) by Bank of America
- Hold Reckitt Benckiser Group (RKT) by Deutsche Bank
- Neutral Bellway (BWY) by Goldman Sachs
- Buy BP (BP.) by Goldman Sachs
- Buy HSBC Holdings (HSBA) by Goldman Sachs
- Hold RS Group (RS1) by Berenberg
Renalytix (Reg S) (RENX) Share Price
Health Care Sector
NOTE: This is based on 14 open tips for Renalytix (Reg S) (RENX)
| Latest Bid : 2.20p | Latest Ask : 2.50p |
| High Today : 2.48p | Low Today : 2.20p |
| This Years High : 10.85p | This Years Low : 2.20p |
| Volume : 325,707 | MKT Cap : £4.44M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Renalytix (Reg S) (RENX) Overview
RenalytixAI is a developer of artificial intelligence (AI) enabled clinical decision support solutions for kidney disease, one of the most common and costly chronic medical conditions globally. RenalytixAI's solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care and patient stratification for drug clinical trials.Renalytix (Reg S) (RENX) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Steve Moore | Premium Only | 2024-08-21 16:20:00 21/08/2024 | 77.62% |
| Add | Christopher Ruane | Premium Only | 2022-06-30 13:50:00 30/06/2022 | -94.20% |
| Buy | Christopher Ruane | Premium Only | 2022-02-23 17:40:00 23/02/2022 | -96.52% |
| Buy | Christopher Ruane | Premium Only | 2022-02-16 11:55:00 16/02/2022 | -97.26% |
| Buy | Christopher Ruane | Premium Only | 2022-01-26 17:40:00 26/01/2022 | -97.68% |
Renalytix (Reg S) (RENX) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 2.20p | Latest Ask : 2.50p |
| High Today : 2.48p | Low Today : 2.20p |
| This Years High : 10.85p | This Years Low : 2.20p |
| Volume : 325,707 | MKT Cap : £4.44M |
Renalytix (Reg S) Overview
RenalytixAI is a developer of artificial intelligence (AI) enabled clinical decision support solutions for kidney disease, one of the most common and costly chronic medical conditions globally. RenalytixAI's solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care and patient stratification for drug clinical trials.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Renalytix (Reg S) Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Steve Moore | Premium Only | 2024-08-21 16:20:00 21/08/2024 | 77.62% |
| Add | Christopher Ruane | Premium Only | 2022-06-30 13:50:00 30/06/2022 | -94.20% |
| Buy | Christopher Ruane | Premium Only | 2022-02-23 17:40:00 23/02/2022 | -96.52% |
| Buy | Christopher Ruane | Premium Only | 2022-02-16 11:55:00 16/02/2022 | -97.26% |
| Buy | Christopher Ruane | Premium Only | 2022-01-26 17:40:00 26/01/2022 | -97.68% |